Protective effect of naringenin-7-O-glucoside against oxidative stress induced by doxorubicin in H9c2 cardiomyocytes

BioScience Trends

Volumn 6, Issue 1, 2012, Pages 19-25

  Han, Xiuzhen ^a   Gao, Si ^a   Cheng, Yanna ^a   Sun, Yanzhe ^a   Liu, Wei ^a   Tang, Linlin ^a   Ren, Dongmei ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

doxorubicin (DOX); Naringenin 7 O glucoside (NARG); reactive oxygen species(ROS)

Indexed keywords

CALCIUM; CREATINE KINASE; DOXORUBICIN; FLAVANONE DERIVATIVE; GLUCOSIDE; GLUTATHIONE PEROXIDASE; LACTATE DEHYDROGENASE; NARINGENIN 7 O GLUCOSIDE; NARINGENIN-7-O-GLUCOSIDE; PROTECTIVE AGENT; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; CELL DEATH; CELL LINE; CELL PROTECTION; CELL SHAPE; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; HEART MUSCLE CELL; INTRACELLULAR SPACE; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT;

ANIMALS; CALCIUM; CELL DEATH; CELL LINE; CELL SHAPE; CREATINE KINASE; CYTOPROTECTION; DOXORUBICIN; FLAVANONES; GLUCOSIDES; GLUTATHIONE PEROXIDASE; INTRACELLULAR SPACE; L-LACTATE DEHYDROGENASE; MYOCYTES, CARDIAC; OXIDATIVE STRESS; PROTECTIVE AGENTS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84862181636     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2012.v6.1.19     Document Type: Article

References (27)

1. Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis. 2007; 49:330-352.
2. 2+ increase are reciprocally modulated in rat cardiomyocytes. Exp Mol Med. 2006; 38:535-545.
3. Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev. 2004; 56:185-229.
4. Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 1999; 57:727-741.
5. Sag CM, Köhler AC, Anderson ME, Backs J, Maier LS. CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes. J Mol Cell Cardiol. 2011; 51:749-759.
6. Simůnek T, Stérba M, Popelová O, Adamcová M, Hrdina R, Gersl V. Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Rep. 2009; 61:154-171.
7. 2+]i increase induced by doxorubicin in ventricular rat cardiomyocytes. Life Sci. 2002; 71:1905-1916.
8. Bast A, Kaiserová H, den Hartog GJ, Haenen GR, van der Vijgh WJ. Protectors against doxorubicin-induced cardiotoxicity: Flavonoids. Cell Biol Toxicol. 2007; 23:39-47.
9. Wu ZY, Li XW. Flora Reipularis Sinicase. Flora Republicae Popularis Sinicae. 1977; 65:378-380. (in Chinese)
10. Ren DM, Guo HF, Wang SQ, Lou HX. Seperation and absolute configuration assignment of two diastereomeric pairs of enantiomers from Dracocephalum rupestre by high-performance liquid chromatography with circular dichroism detection. J Chromatogr A. 2007; 1161:334-337.
11. Ren DM, Guo HF, Yu WT, Wang SQ, Ji M, Lou HX. Stereochemistry of flavonoidal alkaloids from Dracocephalum rupestre. Phytochemistry. 2008; 69:1425-1433.
12. Wang SQ, Han XZ, Li X, Ren DM, Wang XN, Lou HX. Flavonoids from Dracocephalum tanguticum and their cardioprotective effects against doxorubicin-induced toxicity in H9c2 cells. Bioorg Med Chem Lett. 2010; 20:6411-6415.
13. Han X, Ren D, Fan P, Shen T, Lou H. Protective effects of naringenin-7-O-glucoside on doxorubicininduced apoptosis in H9c2 cells. Eur J Pharmacol. 2008; 581:47-53.
14. Han X, Pan J, Ren D, Cheng Y, Fan P, Lou H. Naringenin-7-O-glucoside protects against doxorubicininduced toxicity in H9c2 cardiomyocytes by induction of endogenous antioxidant enzymes. Food Chem Toxicol. 2008; 46:3140-3146.
15. Ren D, Lou H, Ji M. Studies on constituents of Dracocephalum rupestra. Chinese Pharmaceutical Journal. 2005; 40:1695-1696. (in Chinese)
16. Ren DM, Lou HX, Ma B, Ji M. Determination of naringenin-7-O-glucoside and eriodictyol-7-O-glucoside in Dracocephalum rupestra and its different parts by HPLC. Natural Product Research and Development. 2003; 15:229-231. (in Chinese)
17. 2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985; 260:3440-3450.
18. 2+ concentrations and buffering in a dendritic inhibitory hippocampal interneuron. Neuroscience. 2009; 164:1701-1711.
19. Berthiaume JM, Wallace KB. Adriamycin-induced oxidative mitochondrial cardiotoxicity. Cell Biol Toxicol. 2007; 23:15-25.
20. Ferreira AL, Matsubara LS, Matsubara BB. Anthracycline-induced cardiotoxicity. Cardiovasc Hematol Agents Med Chem. 2008; 6:278-281.
21. Jones RL, Swanton C, Ewer MS. Anthracycline cardiotoxicity. Expert Opin Drug Saf. 2006; 5:791-809.
22. Keefe DL. Anthracycline-induced cardiomyopathy. Semin Oncol. 2001; 4:2-7.
23. Salvatorelli E, Guarnieri S, Menna P, Liberi G, Calafiore AM, Mariggio MA, Mordente A, Gianni L, Minotti G. Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart: Relative importance of vesicular sequestration and impaired efficiency of electron addition. J Biol Chem. 2006; 281:10990-11001.
24. Sadzuka Y, Sugiyama T, Shimoi K, Kinae N, Hirota S. Protective effect of flavonoids on doxorubic-ininduced cardiotoxicity. Toxicol Lett. 1997; 92:1-7.
25. van Acker SA, van Balen GP, van den Berg DJ, Bast A, van der Vijgh WJ. Influence of iron chelation on the antioxidant activity of flavonoids. Biochem Pharmacol. 1998; 56:935-943.
26. Bast A, Kaiserová H, den Hartog GJ, Haenen GR, van der Vijgh WJ. Protectors against doxorubicin-induced cardiotoxicity: Flavonoids. Cell Biol Toxicol. 2007; 23:39-47.
27. Crespo I, García-Mediavilla MV, Almar M, González P, Tuñón MJ, Sánchez-Campos S, González-Gallego J. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and changes in antioxidant enzyme expression induced by proinflammatory cytokines in Chang Liver cells. Food Chem Toxicol. 2008; 46:1555-1569.